Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5992621 | 0.88 | SMN1; SMN2 (0.44) | ALDH1A1LMNAKDM4ERAB9AKMT2A | |
| SCHEMBL8479485 | 0.70 | ALDH1A1 (0.49) | ALDH1A1LMNAKDM4ENPC1RAB9A | |
| SCHEMBL1954826 | 0.68 | SIGMAR1 (0.44) | ALDH1A1LMNAKDM4ENPC1RAB9A | |
| SCHEMBL29624292 | 0.67 | SIGMAR1 (0.43) | ALDH1A1LMNAKDM4ENPC1RAB9A | |
| SCHEMBL28624432 | 0.66 | RAB9A (0.51) | ALDH1A1LMNANPC1RAB9AKMT2A | |
| SCHEMBL4919799 | 0.65 | SIGMAR1 (0.42) | ALDH1A1LMNAKDM4ENPC1RAB9A | |
| SCHEMBL28872509 | 0.65 | SMN1; SMN2 (0.65) | ALDH1A1LMNANPC1RAB9AKMT2A | |
| Hydrochloric Acid SCHEMBL27750411 | 0.65 | SIGMAR1 (0.54) | ALDH1A1LMNA | |
| SCHEMBL8336714 | 0.65 | SIGMAR1 (0.42) | ALDH1A1LMNAKDM4ENPC1RAB9A | |
| SCHEMBL30102091 | 0.65 | RAB9A (0.73) | ALDH1A1LMNAKDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10730848-B2 | Protective molecules against anthrax toxin | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-08-04 | — | — | US | disclosed |
| US-20160016930-A1 | PROTECTIVE MOLECULES AGAINST ANTHRAX TOXIN | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160016930-A1 | PROTECTIVE MOLECULES AGAINST ANTHRAX TOXIN | ANTXR2, TSG101, ANXA1 | ALDH1A1 3473/4885LMNA 368/4885KDM4E 4777/4885 |
| US-10730848-B2 | Protective molecules against anthrax toxin | ANTXR2, TSG101, ANXA1 | ALDH1A1 3473/4885LMNA 368/4885KDM4E 4777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.